Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 801–900 of 1,016
Quinn, M. A., & Cidlowski, J. A. (2016) · The FASEB Journal · doi:10.1096/fj.15-278309 · Cited by 40
Self-citationPharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review
Farzan, N., Vijverberg, S. J. H., Arets, H. G. M., Raaijmakers, J. A. M., & der Zee, A. H. M. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12844 · Cited by 43
TRPM8 in the negative regulation of TNFα expression during cold stress
Wang, X.-P., Yu, X., Yan, X.-J., Fan, L., Chai, Y., Jiang, J.-F., Yuan, Z., Xing, D., & Du, L. (2017) · Scientific Reports · doi:10.1038/srep45155 · Cited by 43
Yu, H. N., Wu, M., Lu, G., Cao, T., Chen, N., Zhang, Y., Jiang, Z., Fan, H., & Yao, R. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.034 · Cited by 46
Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders
Olan, T. S. , Siritho, S., Kittisares, K., Jitprapaikulsan, J., Sathukitchai, C., & Prayoonwiwat, N. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.010 · Cited by 43
Ayroldi, E., Cannarile, L., Delfino, D. V., & Riccardi, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0558-1 · Cited by 49
“myeloma cells, through an unknown mechanism, GILZ mediates GC apoptotic effects (3).”
Ruiz‐Irastorza, G., Ugarte, A., Ruiz‐Arruza, I., & Khamashta, M. A. (2020) · Lupus · doi:10.1177/0961203320930099 · Cited by 48
“The result of this socalled transrepression is a reduction in the synthesis of proinflammatory cytokines such as interleukin (IL) 6 and TNFa.(5,6) In addition, the glucocorticoid–cGR complex binds directly to certain DNA sequences named glucocorticoid responding elements, activating the transcription of specific genes…”
BackgroundNanomedicine for the prevention, treatment and imaging of atherosclerosis
Psarros, C. T., Lee, R., Margaritis, M., & Antoniades, C. A. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.014 · Cited by 48
Wang, L., Liu, J., Zhang, A., Cheng, P., Zhang, X., Lv, S., Wu, L., Yu, J., Di, W., Zha, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040056 · Cited by 50
“On the other hand, the profound effects of glucocorticoid on the immune system preclude its widespread use as a therapeutic agent for inflammatory diseases [19].”
BackgroundPsychosocial stress and cancer risk: a narrative review
Mohan, A., Huybrechts, I., & Michels, N. (2022) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000752 · Cited by 48
“The glucocorticoids are in acute states also responsible for inflammation suppression (Ruzek et al., 1999; Rhen and Cidlowski, 2005; Pace et al., 2007; Schoneveld and Cidlowski, 2007).”
BackgroundÖztürk, M., Tel‐Çayan, G., Muhammad, A., Terzioğlu, P., & Duru, M. E. (2015) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63473-3.00010-1 · Cited by 53
The effects of corticosteroids on COPD lung macrophages: a pooled analysis
Higham, A., Booth, G. C., Lea, S., Southworth, T. W., Plumb, J., & Singh, D. (2015) · Respiratory Research · doi:10.1186/s12931-015-0260-0 · Cited by 42
“Corticosteroids bind to and activate the glucocorticoid receptor (GR) [5], resulting in GR nuclear translocation and the subsequent transrepression of inflammatory gene transcription by inhibition of the activity of transcription factors such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [6…”
BackgroundJin, S., Ge, Y., Zhuang, S., Wang, L., Chen, S., & Gong, R. (2013) · Kidney International · doi:10.1038/ki.2012.447 · Cited by 43
“30 Thus the beneficial effect of ACTH on AKI observed in this study might be explained partially by the steroidogenic action through which ACTH upregulates corticosterone production and subsequently suppresses TNF induced acute inflammatory injury in the kidney.”
Ghoneim, H. E., & McCullers, J. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit653 · Cited by 45
“can cause systemic immunosuppression [17, 31].”
BackgroundStapleton, P., Crighton, G. J., Sabot, D., & O’Neill, H. M. (2020) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000563 · Cited by 46
Pianca, N., Sacchi, F., Umansky, K. B., Chirivì, M., Iommarini, L., Pra, S. D., Papa, V., Bongiovanni, C., Miano, C., Pontis, F., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00090-0 · Cited by 43
Wang, H., ZHANG, L., Jiang, N., Wang, Z., CHONG, Y., & Fu, F. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1128 · Cited by 46
Millar, K., Manlhiot, C., Yeung, R. S. M., Somji, Z., & McCrindle, B. W. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.070 · Cited by 42
“The glucocorticoid receptor is a member of the steroid-hormone-receptor family of proteins [37].”
BackgroundPetri, M., Bechtel, B., Dennis, G. J., Shah, M. B., McLaughlin, T. P., Kan, H., & Molta, C. T. (2014) · Lupus · doi:10.1177/0961203314532699 · Cited by 42
Ray, J. A., Kushnir, M. M., Rockwood, A. L., & Meikle, A. W. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.016 · Cited by 42
Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate
Gyllfors, P., Dahlén, S., Kumlin, M., Larsson, K., & Dahlén, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.040 · Cited by 42
Li, X., Liang, T., Dai, B., Chang, L., Zhang, Y., Hu, S., Guo, J., Xu, S., Zheng, L., Yao, H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci166795 · Cited by 41
“Upon binding of GCs to the GR in the cytoplasm, GR translocates to the nucleus, where it regulates gene expression by binding to GC response elements within the promoters of various genes (44).”
Wang, M., Ramírez, J. A., Han, J., Jia, Y., Domenico, J. M., Seibold, M. A., Hagman, J. R., & Gelfand, E. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.027 · Cited by 42
L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells
Ayroldi, E., Petrillo, M. G., Bastianelli, A., Marchetti, M. C., Ronchetti, S., Nocentini, G., Ricciotti, L., Cannarile, L., & Riccardi, C. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.129 · Cited by 44
“Glucocorticoids (GCs) exert major anti-inflammatory/ immunosuppressive effects and act as anti-tumor agents in the treatment of several hematologic malignancies and solid tumors.(13) Most GC-elicited effects result from the transcriptional regulation of GC receptor (GR) target genes.”
BackgroundNeural reflex pathways in intestinal inflammation: hypotheses to viable therapy
Willemze, R. A., Luyer, M. D. P., Buurman, W. A., & de Jonge, W. J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.56 · Cited by 48
Kim, Y., Jung, J., Jung, S.-Y., Yu, S., Lee, K. W., & Park, Y. J. (2015) · Cornea · doi:10.1097/ico.0000000000000695 · Cited by 41
Zhang, B., Zhang, Y., Xu, T., Yin, Y., Huang, R., Wang, Y., Zhang, J., Huang, D., & Li, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.039 · Cited by 41
Loneliness and biological responses to acute stress in people with Type 2 diabetes
Hackett, R. A., Poole, L., Hunt, E., Panagi, L., & Steptoe, A. (2019) · Psychophysiology · doi:10.1111/psyp.13341 · Cited by 43
Wang, S., Ai, J., Cui, P., Zhu, Y., Wu, H., & Zhang, W. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.30 · Cited by 41
“The most common of these treatments is the therapeutic application of glucocorticoids for a variety of diseases due to their anti-inflammatory and immunosuppressive properties (2).”
BackgroundHsieh, M.-H., Watanabe, T., & Aihara, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.636924 · Cited by 42
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
Vatrella, A., Maglio, A., Pelaia, C., Ciampo, L., Pelaia, G., & Vitale, C. (2022) · Biomedicines · doi:10.3390/biomedicines10092181 · Cited by 40
Westra, Lane, S. S., Coffey, A., & DeCory, H. H. (2013) · Clinical ophthalmology · doi:10.2147/opth.s40588 · Cited by 41
“Corticosteroids mediate their effects primarily by binding to and modifying the activity of cytosolic glucocorticoid receptor (GR) at the genomic level.(1,3,4) Corticosteroids bind to the GR in the cytoplasm, after which the corticosteroid-GR complex migrates to the nucleus and inhibits the expression of pro-inflammat…”
Moreau, M. E., Bawolak, M., Morissette, G., Adam, A. A., & Marceau, F. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030684 · Cited by 41
“The activated glucocorticoid receptor may inhibit NF- B translocation through the stimulation of the de novo synthesis of I B (an endogenous inhibitor of translocation) but is mainly inhibitory through a protein-protein interaction with activated NF- B in the nucleus (Rhen and Cidlowski, 2005).”
BackgroundOral extended release of dexamethasone: Montmorillonite–PLGA nanocomposites as a delivery vehicle
Jain, S., & Datta, M. (2014) · Applied Clay Science · doi:10.1016/j.clay.2014.11.028 · Cited by 43
Analysis of the bovine neutrophil transcriptome during glucocorticoid treatment
Weber, P. S. D., Madsen‐Bouterse, S. A., Rosa, G. J. M., Sipkovsky, S., Ren, X., de Almeida, P. E., Kruska, R., Halgren, R. G., Barrick, J. L., & Burton, J. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00094.2006 · Cited by 50
“GLUCOCORTICOIDS ARE STEROID hormones well known for their potent therapeutic anti-inflammatory properties (25, 51, 76).”
BackgroundGlucocorticoid-Induced Osteoporosis: Mechanisms and Therapeutic Approach
Devogelaer, J. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.09.001 · Cited by 45
Corvol, H., Nathan, N., Muselet-Charlier, C., Chadelat, K., Rouzic, P. L., Tabary, O., Fauroux, B., Henrion‐Caude, A., Feingold, J., Boëlle, P., et al. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-88 · Cited by 48
“Within the cell, the cortisol-GR complex can bind as a homodimer to the glucocorticoid-response elements and enhance or represses transcription of specific target genes [31].”
BackgroundCritical evaluation of human endometrial explants as an ex vivo model system: a molecular approach
Schafer, W. R., Fischer, L., Roth, K., Jullig, A. K., Stuckenschneider, J., Schwartz, P. J., Weimer, M. S., Orlowska‐Volk, M., Hanjalic-Beck, A., Kranz, I., et al. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq095 · Cited by 41
Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS
Li, L., Zhang, T., Diao, W., Jin, F., Shi, L., Meng, J., Liu, H., Zhang, J., Zeng, C.-H., Zhang, M.-C., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050468 · Cited by 38
Cell Cycle Phase Regulates Glucocorticoid Receptor Function
Matthews, L. C., Johnson, J. R., Berry, A. A., Trebble, P., Cookson, A., Spiller, D. G., Rivers, C. A., Norman, M., White, M., & Ray, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022289 · Cited by 47
“(GR) [1,5], a member of the nuclear hormone receptor”
BackgroundIlowite, N. T., & Laxer, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10006-8 · Cited by 42
Lindberg-Larsen, V., Ostrowski, S. R., Lindberg‐Larsen, M., Rovsing, M. L., Johansson, P. I., & Kehlet, H. (2017) · Anaesthesia · doi:10.1111/anae.13983 · Cited by 41
“well-documented anti-inflammatory effects [17].”
Zhang, J., Ge, P., Liu, J., Luo, Y., Guo, H., Zhang, G., Xu, C., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512138 · Cited by 47
Leikfoss, I. S., Mero, I.-L., Dahle, M. K., Lie, B. A., Harbo, H. F., Spurkland, A., & Berge, T. (2012) · Genes and Immunity · doi:10.1038/gene.2012.52 · Cited by 41
Torkildsen, G. L., Cockrum, P. C., Meier, E. J., Hammonds, W. M., Silverstein, B. E., & Silverstein, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.539603 · Cited by 40
Estrada-López, E. D., Murce, E., Franca, M. P. P., & Pimentel, A. S. (2017) · RSC Advances · doi:10.1039/c6ra28422a · Cited by 40
Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone
Chuang, T.-Y., Cheng, A.-J., Chen, I., Lan, T.-Y., Huang, I.-H., Shiau, C., Hsu, C., Liu, Y., Chang, Z.-F., Tseng, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17683 · Cited by 43
Sonnappa, S., Martin, R. J., Israel, E., Postma, D. S., van Aalderen, W. M. C., Burden, A., Usmani, O. S., Price, D. B., & on behalf of the Respiratory Effectiveness Group, S. A. S. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178112 · Cited by 41
“[7–9] Indeed, regular use of ICS has been linked to several systemic effects,[10] including a higher risk of pneumonia,[9,11–16] where it is thought that ICS exert an anti-inflammatory and immunosuppressive effect that could affect the pathogenesis of pneumonia.[17] Most randomized controlled trials (RCTs),[14,15,18]…”
BackgroundSide Effects of Glucocorticoids
ALAN, İ. S., & Alan, B. (2018) · InTech eBooks · doi:10.5772/intechopen.72019 · Cited by 42
“GCs also inhibit secretion and synthesis of inflammatory molecules (IL-1, IL-2, IL-6, IL-8, tumor necrosis factor, inflammatory eicosanoids, and cyclooxygenase-2) by affecting posttranslational events [23].”
Assali, M., Shawahna, R., Dayyeh, S., Shareef, M., & Alhimony, I.-A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.07.012 · Cited by 44
The Emerging Role of Pathogenesis of IgA Nephropathy
Wu, M., Chen, C., Yiang, G., Cheng, P., Chen, Y., Chiu, H.-C., Liu, K., Lee, W., & Li, C.-J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080225 · Cited by 41
“In vitro studies have demonstrated that corticosteroids decrease the production of prostaglandin by activating annexin I and inhibiting the production of arachidonic acid [92,93].”
BackgroundKimura, S., Ahn, J. B., Takahashi, M., Kwon, S., & Papatheodorou, S. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00773-6 · Cited by 40
Modulation of Inflammatory Mediators by Polymeric Nanoparticles Loaded with Anti-Inflammatory Drugs
Pontes-Quero, G. M., Benito-Garzón, L., Cano, J. P., Aguilar, M. R., & Vázquez‐Lasa, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020290 · Cited by 43
“Finally, DEX is a glucocorticoid whose anti-inflammatory potential is mainly mediated by its binding to the glucocorticoid receptor, which is activated and translocated to the nucleus of immune cells, inducing or repressing the transcription of multiple inflammation related genes [73].”
BackgroundLi, M., Lu, C., Zhang, L., Zhang, J., Du, Y., Duan, S., Wang, T., & Fu, F. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/503617 · Cited by 40
“It is well known that glucocorticoids (GCs) and nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common medications for acute and chronic inflammation, such as sepsis, rheumatoid arthritis, and ulcerative colitis [1, 2].”
BackgroundMarwick, J. A., Adcock, I. M., & Chung, K. F. (2010) · Drugs · doi:10.2165/10898520-000000000-00000 · Cited by 50
“Upon glucocorticoid binding, GRa dissociates from this complex and translocates to the nucleus where it mediates both repression and induction of gene expression (figure 1).([14,15]) The exact contributions of GRa-mediated gene repression (transrepression) and gene activation (transactivation) to the anti-inflammatory…”
BackgroundMiller, A. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.018 · Cited by 40
“Indeed, in addition to glucocorticoid induction of Inhibitor of kappa B (IkB) (which stabilizes NF-kB in the cytosol, thereby preventing its nuclear translocation), nuclear GR-NF-kB proteinprotein interactions are believed to play a primary role in the capacity of glucocorticoids to inhibit NF-kB DNA binding and thus…”
BackgroundCaveolin-1 Regulates Genomic Action of the Glucocorticoid Receptor in Neural Stem Cells
Peffer, M. E., Chandran, U. R., Luthra, S., Volonté, D., Galbiati, F., Garabedian, M. J., Monaghan, A. P., & DeFranco, D. B. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01121-13 · Cited by 41
“Given their potent anti-inflammatory actions, GCs are widely used therapeutically in children and adults to treat a variety conditions and diseases such as asthma, allergies, rheumatoid arthritis, chronic inflammation, and induction treatment for acute leukemias (2).”
BackgroundClinical, mechanistic, and therapeutic landscape of cutaneous fibrosis
Li, D. J., Berry, C. E., Wan, D. C., & Longaker, M. T. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn7871 · Cited by 46
“Because of their broad inhibitory effects on cytokine production, T and B cell function, and, to some degree, fibroblast activation ( 100 ), topical, intralesional, and systemic glucocorticoids have been effective in reducing the size and stiffness of cutaneous fibrosis in hypertrophic and keloidal…”
BackgroundZhu, X. O., Yang, Z. H., Guo, C., Ni, X., Li, J. N., Ge, Y. C., Myatt, L., & Sun, K. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0201 · Cited by 40
“As a well-recognized antiinflammatory hormone, glucocorticoids inhibit COX-2 expression and PG synthesis in virtually every known system (10, 11).”
BackgroundResultInfluentialKalafatakis, K., Russell, G. M., Ζάρρος, Α., & Lightman, S. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.009 · Cited by 43
“The wide spectrum of GC-related biological actions, apart from indicating their generic significance in human (and many other animal species’) physiology, has been exploited in the field of therapeutics of various disorders; natural or synthetic GCs are prescribed/used in several clinical conditions for instance infla…”
Schmidt, T., Hoch, M., Jad, S. S. L., Solimani, F., Zenzo, G. D., Marzano, A. V., Goebeler, M., Cozzani, E., Kern, J. S., Sitaru, C., et al. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15800 · Cited by 39
Ummarino, A., Gambaro, F. M., Kon, E., & Torres, F. (2020) · Nanomaterials · doi:10.3390/nano10081562 · Cited by 41
“Corticosteroids are a class of steroid hormones with a powerful anti-inflammatory effect that is mediated by their binding to the glucocorticoid receptor, which is activated and translocated to the nucleus of immune cells, activating the synthesis of lipocortin-1 and gluconeogenesis, among others [58].”
BackgroundClinical Aspects and Current Therapeutic Approaches for FOP
Kitoh, H. (2020) · Biomedicines · doi:10.3390/biomedicines8090325 · Cited by 40
“The use of short-ter high-dose corticosteroids is based on its potent anti-inflammatory effects [40].”
BackgroundWithametelin: a biologically active withanolide in cancer, inflammation, pain and depression
Baig, M. W., Nasir, B., Waseem, D., Majid, M., Khan, M. Z. I., & Haq, I. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.09.021 · Cited by 40
“Likewise, glucocorticoid receptor is an important antiinflammatory and analgesic target via different mechanisms (Lim et al., 2005, Rhen and Cidlowski, 2005).”
Oh, S., Yang, J., Park, C., Son, K., & Byun, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158057 · Cited by 41
“Although GCs are representative anti-inflammatory and immunosuppressive agents [43], they also stimulate inflammatory signaling pathways that lead to muscle atrophy [44].”
BackgroundThe clinical significance of the glucocorticoid receptors: Genetics and epigenetics
Motavalli, R., Majidi, T., Pourlak, T., Abediazar, S., Shoja, M. M., Vahed, S. Z., & Etemadi, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105952 · Cited by 42
Androgens Alleviate Allergic Airway Inflammation by Suppressing Cytokine Production in Th2 Cells
Ejima, A., Abe, S., Shimba, A., Satô, S., Uehata, T., Tani‐ichi, S., Munakata, S., Cui, G., Takeuchi, O., Hirai, T., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200294 · Cited by 39
Neural mechanisms underlying chronic fatigue
Tanaka, M., Ishii, A., & Watanabe, Y. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0035 · Cited by 40
Glucocorticoid-induced MIF expression by human CEM T cells
Leng, L., Wang, W., Roger, T., Merk, M., Wuttke, M., Calandra, T., & Bucala, R. (2009) · Cytokine · doi:10.1016/j.cyto.2009.07.002 · Cited by 44
Antiinflammatory Effects of Budesonide in Human Fetal Lung
Barrette, A. M., Roberts, J. K., Chapin, C. J., Egan, E. A., Segal, M. R., Osés-Prieto, J. A., Chand, S., Burlingame, A. L., & Ballard, P. L. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0068oc · Cited by 44
“Among the repressed genes, some are known targets for the transcription factor NF-kB (Table 2); the inhibitory mechanism of corticosteroids related to NF-kB target genes involves direct interaction of the GRglucocorticoid complex with NF-kB and the inhibition of its transcriptional activation activity at promoter regu…”
BackgroundCruz‐Topete, D., He, B., Xu, X., & Cidlowski, J. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725903 · Cited by 41
“Glucocorticoids are essential steroid hormones synthesized and secreted by the adrenal glands in a diurnal fashion and in response to stress (1, 2).”
BackgroundSelf-citationMcSorley, S. T., Roxburgh, C. S. D., Horgan, P. G., & McMillan, D. C. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5817-3 · Cited by 39
“65–74 106 (38) 49 (36) 57 (42) [74 68 (25) 35 (25) 33 (24)”
Dang, T. T., Bratlie, K. M., Bogatyrev, S. R., Chen, X. Y., Langer, R., & Anderson, D. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.048 · Cited by 38
“Though the mechanism of action for dexamethasone is not completely understood, it is known toact via avarietyof pathways [33] resulting in the attenuation of inflammatory cell cascades when administered systemically [45].”
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
Budhathoki, P., Shrestha, D. B., Rawal, E., & Khadka, S. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00515-6 · Cited by 38
“Thus, the anti-inflammatory mechanism is the basis for using it in various medical conditions including bacterial or viral pneumonia [3, 4].”
BackgroundTherapies for Chronic Spontaneous Urticaria: Present and Future Developments
Asero, R., Calzari, P., Vaienti, S., & Cugno, M. (2024) · Pharmaceuticals · doi:10.3390/ph17111499 · Cited by 41
Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels
Yang, C., Mariner, P. D., Nahreini, J. N., & Anseth, K. S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.002 · Cited by 44
“To overcome these targeting issues, high doses of glucocorticoids are often administered, leading to unintended side effects in surrounding tissues [6–9].”
BackgroundClinical Applications of Dexamethasone for Aged Eyes
Abadía, B., Calvo, P., Ferreras, A., Bartol-Puyal, F. D. A., Verdes, G., & Pablo, L. E. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0392-z · Cited by 41
Kostopoulou, O. N., Mohammad, A., Bartek, J. J., Winter, J., Jung, M., Stragliotto, G., Söderberg‐Nauclér, C., & Landázuri, N. (2017) · International Journal of Cancer · doi:10.1002/ijc.31132 · Cited by 46
“Synthetic GCs with longer bioavailability and stronger affinity for the GC receptor are widely prescribed as antiinflammatory and immunosuppressive agents.(8) They are also used to treat hematological malignancies, as they appear to induce apoptosis of malignant cells through poorly understood mechanisms.”
BackgroundZhang, L., Zhou, J., Jing, Z., Yu, X., Sun, Y., Wu, Y., & Sun, H. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.002 · Cited by 39
“…2009; del Porto et al., 2010; Ait-Oufella et al., 2013). guanky@163.com (Z. Jing). en access article under the CC BY-NC Glucocorticoids have been widely used in clinical practice by reason of the powerful and effective anti-inflammatory properties (Rhen and Cidlowski, 2005; Owens et al., 2014).”
MethodDistinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications
Choi, Y., Sim, S., & Park, H. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.022 · Cited by 39
“At the gene expression level, they increase or decrease various transcription factors related to airway inflammation [70].”
BackgroundPhysiologically Based Pharmacokinetics of Dexamethasone in Rats
Song, D., Sun, L., DuBois, D. C., Almon, R. R., Meng, S., & Jusko, W. J. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.091017 · Cited by 38
“The CSs have strong immunosuppressive and anti-inflammatory properties, which provide the foundation for their wide application in conditions including organ transplants, rheumatoid arthritis, some lymphomas, and many others (Rhen and Cidlowski, 2005; Kadmiel and Cidlowski, 2013).”
BackgroundNonrespiratory Comorbidities in Asthma
Cardet, J. C., Bulkhi, A. A., & Lockey, R. F. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.08.027 · Cited by 44
van der Meulen, M., Amaya, J. M., Dekkers, O. M., & Meijer, O. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062446 · Cited by 41
Identification of global inhibitors of cellular glycosylation
Sørensen, D. M., Büll, C., Madsen, T. D., Lira‐Navarrete, E., Clausen, T. M., Clark, A. E., Garretson, A. F., Karlsson, R. T. G., Pijnenborg, J. F. A., Yin, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36598-7 · Cited by 41
Yennurajalingam, S., & Bruera, E. D. (2014) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000093 · Cited by 41
Regulatory and effector T-cells are differentially modulated by Dexamethasone
Pandolfi, J. B., Baz, P., Fernández, P. M., Lupi, A. D. D., Payaslián, F., Billordo, L. A., Fainboim, L., & Arruvito, L. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.008 · Cited by 40
Chang, S., Yang, L.-M., Lo, C.-H., Liaw, J., Wang, L., & Lin, S. (2008) · Journal of Natural Products · doi:10.1021/np070468g · Cited by 38
Effect of Immunomodulating Medications in Complex Regional Pain Syndrome: A Systematic Review
Dirckx, M., Stronks, D. L., Groeneweg, G., & Huygen, F. J. P. M. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31822efe30 · Cited by 38
“Glucocorticoids can also inhibit prostaglandin production through some independent mechanisms.(22) TUMOR NECROSIS FACTOR-a ANTAGONISTS Tumor necrosis factor alpha (TNF-a) is a cytokine that promotes an inflammatory response.”
BackgroundBaquié, M., St-Onge, L., Kerr-Conte, J., Cobo-Vuilleumier, N., Lorenzo, P. I., Jimenez Moreno, C. M., Cederroth, C. R., Nef, S., Borot, S., Bosco, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr193 · Cited by 41
“Glucocorticoids are potent immunosuppressive agents that blunt inflammation by inhibiting expression of cytokines with a concomitant increase in anti-inflammatory proteins (36).”
BackgroundBlack, D. S., Peng, C., Sleight, A. G., Nguyen, N. T., Lenz, H., & Figueiredo, J. C. (2017) · Cancer · doi:10.1002/cncr.30698 · Cited by 42
“lates the anterior pituitary to secrete adrenocorticotropic hormone to trigger the adrenal glands atop the kidneys to release the corticosteroid hormone cortisol.(4,5) Chronic activation of this system in patients with cancer, especially those with”
BackgroundWater Pharmacophore: Designing Ligands using Molecular Dynamics Simulations with Water
Jung, S. W., Kim, M., Ramsey, S., Kurtzman, T., & Cho, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-28546-z · Cited by 40
Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery
Kang, S., Park, T. H., Chen, X., Dickens, G., Lee, B., Lu, K., Rakhilin, N., Daniel, S., & Jin, M. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.046 · Cited by 41
Therapeutic approaches for control of transcription factors in allergic disease
Cousins, D. J., McDonald, J., & Lee, T. H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.008 · Cited by 44
Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37
“GCs and their synthetic analogs have been widely prescribed as medications for their anti-inflammatory and immunosuppressive properties (Rhen and Cidlowski, 2005).”
BackgroundEffect of DMARDs on the immunogenicity of vaccines
van Sleen, Y., van der Geest, K. S. M., Huckriede, A. L. W., van Baarle, D., & Brouwer, E. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00992-8 · Cited by 43
Endogenous glucocorticoids in inflammation: contributions of systemic and local responses
Hardy, R., Raza, K., & Cooper, M. S. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13650 · Cited by 43
Diniz, L., Santos, T. B., Britto, L. R. G., Céspedes, I. C., Garcia, M. C., Spadari-Bratfisch, R. C., Medalha, C. C., de Castro, G. M., Montesano, F. T., & Viana, M. D. B. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.024 · Cited by 40
“Glucocorticoid receptors are intracellular receptors that bind to nuclear proteins [32] and to transcription factors, such as c-jun and c-fos, thus regulating gene transcription [33,34].”
BackgroundEvolving paradigms in the nutritional support of critically ill surgical patients
Rosenthal, M. D., Vanzant, E. L., Martindale, R. G., & Moore, F. A. (2015) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2015.02.003 · Cited by 37
The current relevance and use of prednisone in rheumatoid arthritis
Krasselt, M., & Baerwald, C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.904746 · Cited by 39
Beaudry, J. L., Dunford, E. C., Teich, T., Zaharieva, D. P., Hunt, H., Belanoff, J. K., & Riddell, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091248 · Cited by 41
“tion [4] and energy homeostasis [5,6].”
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.